320 related articles for article (PubMed ID: 25239274)
21. Fine-needle aspiration cytology of non-small cell lung carcinoma: A paradigm shift.
Dey P; Ghosh RK
Diagn Cytopathol; 2019 Apr; 47(4):351-358. PubMed ID: 30499220
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Pathological Characteristics of
Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
[No Abstract] [Full Text] [Related]
23. Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer.
Kulesza P; Ramchandran K; Patel JD
Am J Clin Pathol; 2011 Aug; 136(2):228-38. PubMed ID: 21757595
[TBL] [Abstract][Full Text] [Related]
24. Current and future trends in non-small cell lung cancer biomarker testing: The American experience.
VanderLaan PA; Roy-Chowdhuri S
Cancer Cytopathol; 2020 Sep; 128(9):629-636. PubMed ID: 32885913
[TBL] [Abstract][Full Text] [Related]
25. Should we continue to use the term non-small-cell lung cancer?
Gazdar AF
Ann Oncol; 2010 Oct; 21 Suppl 7(Suppl 7):vii225-9. PubMed ID: 20943619
[TBL] [Abstract][Full Text] [Related]
26. Molecular Pathology of Lung Cancer.
Roy-Chowdhuri S
Clin Lab Med; 2024 Jun; 44(2):137-147. PubMed ID: 38821637
[TBL] [Abstract][Full Text] [Related]
27. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
Byeon S; Lee B; Park WY; Choi YL; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Clin Lung Cancer; 2020 May; 21(3):e182-e190. PubMed ID: 31839532
[TBL] [Abstract][Full Text] [Related]
28. Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice?
Vigliar E; Malapelle U; Bellevicine C; de Luca C; Troncone G
Cytopathology; 2015 Oct; 26(5):312-7. PubMed ID: 25376259
[TBL] [Abstract][Full Text] [Related]
29. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
[TBL] [Abstract][Full Text] [Related]
30. [Advances on driver oncogenes of non-small cell lung cancer].
Zhao J; Xiong J
Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):42-7. PubMed ID: 25603872
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathology of non-small cell lung cancer: a practical guide.
Aisner DL; Marshall CB
Am J Clin Pathol; 2012 Sep; 138(3):332-46. PubMed ID: 22912349
[TBL] [Abstract][Full Text] [Related]
32. Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer.
Ionescu DN; Stockley TL; Banerji S; Couture C; Mather CA; Xu Z; Blais N; Cheema PK; Chu QS; Melosky B; Leighl NB
Curr Oncol; 2022 Jul; 29(7):4981-4997. PubMed ID: 35877256
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
Warth A
Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
[TBL] [Abstract][Full Text] [Related]
34. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
[TBL] [Abstract][Full Text] [Related]
35. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.
Han B; Tjulandin S; Hagiwara K; Normanno N; Wulandari L; Laktionov K; Hudoyo A; He Y; Zhang YP; Wang MZ; Liu CY; Ratcliffe M; McCormack R; Reck M
Lung Cancer; 2017 Nov; 113():37-44. PubMed ID: 29110846
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Ishikawa Y; Wistuba I; Flieder DB; Franklin W; Gazdar A; Hasleton PS; Henderson DW; Kerr KM; Petersen I; Roggli V; Thunnissen E; Tsao M
Arch Pathol Lab Med; 2013 May; 137(5):668-84. PubMed ID: 22970842
[TBL] [Abstract][Full Text] [Related]
37. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.
Billah S; Stewart J; Staerkel G; Chen S; Gong Y; Guo M
Cancer Cytopathol; 2011 Apr; 119(2):111-7. PubMed ID: 21400670
[TBL] [Abstract][Full Text] [Related]
38. Molecular Testing in Lung Cancer: Recommendations and Update.
Borczuk AC
Surg Pathol Clin; 2024 Jun; 17(2):307-320. PubMed ID: 38692813
[TBL] [Abstract][Full Text] [Related]
39. Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
Zhou F; Moreira AL
Arch Pathol Lab Med; 2016 Dec; 140(12):1331-1337. PubMed ID: 27588333
[TBL] [Abstract][Full Text] [Related]
40. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
Hensing T; Chawla A; Batra R; Salgia R
Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
